GlassScriptPhysician profile
Ralph Guarneri
NPI 1699773341
$49,515.77
in general payments reported to CMS, 2019-2025
30 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,314 · 2020: $9,299 · 2021: $1,272 · 2022: $7,751 · 2023: $7,327 · 2024: $2,826 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $8,553 · Long Term Medical Supply Or Device Loan: $147 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,157.01 |
| Food and Beverage | $8,552.74 |
| Long Term Medical Supply Or Device Loan | $146.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $39,112.54 | 2019-2025 | Da Vinci Surgical System |
| Aroa Biosurgery Incorporated | $1,455.85 | 2022-2025 | |
| Ethicon US, LLC | $1,379.76 | 2019-2025 | Vistaseal, Echelon; Endopath, Harmonic |
| W. L. Gore & Associates, INC. | $822.04 | 2022-2025 | Gore Enform Preperitoneal Biomaterial |
| Davol INC. | $719.21 | 2020-2025 | Phasix Mesh |
| Tela Bio, INC. | $611.37 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Csl Behring | $527.02 | 2019-2024 | Kcentra |
| Medical Device Business Services, INC. | $502.32 | 2023-2024 | |
| Kerecis Limited | $497.86 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $455.92 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Covidien LP | $437.49 | 2019 | |
| Acumed LLC | $350.21 | 2023 | Osteomed, Ribloc |
| Stryker Corporation | $339.30 | 2022-2025 | Spy-Phi System |
| Atricure, INC. | $301.61 | 2024 | |
| Kci USA, INC. | $282.74 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up France Sas | $264.92 | 2021 | |
| Heron Therapeutics, INC. | $237.71 | 2021-2024 | Zynrelef |
| Acell, INC. | $170.41 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $166.29 | 2023 | Caldolor |
| Innovation Technologies INC | $158.77 | 2024 | Irrisept |
| Takeda Pharmaceuticals U.S.A., INC. | $137.52 | 2025 | Gattex |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $124.70 | 2023 | Iovera |
| Medline Industries LP | $114.70 | 2019 | |
| Conmed Corporation | $31.98 | 2021 | |
| Melinta Therapeutics, LLC | $20.79 | 2024 | Rezzayo |
| Paratek Pharmaceuticals, INC. | $15.62 | 2020 | |
| Convatec INC. | $13.02 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Guarneri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.